Title | OncoTargets and Therapy |
Abbreviation | OncoTargets Ther. |
Publication Type | Journal |
Subject Area, Categories, Scope | Oncology (Q2); Pharmacology (medical) (Q2) |
h-index | 86 |
Overall Rank/Ranking | 6118 |
SCImago Journal Rank (SJR) | 0.81 |
Impact Score | 2.67 |
Publisher | Dove Medical Press Ltd. |
Country | New Zealand |
ISSN | 11786930 |
Best Quartile | Q2 |
Coverage History | 2009-2023 |
OncoTargets and Therapy is a journal covering the technologies/fields/categories related to Oncology (Q2); Pharmacology (medical) (Q2). It is published by Dove Medical Press Ltd.. The overall rank of OncoTargets and Therapy is 6118. According to SCImago Journal Rank (SJR), this journal is ranked 0.81. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 86. The best quartile for this journal is Q2.
The ISSN of OncoTargets and Therapy journal is 11786930. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. OncoTargets and Therapy is cited by a total of 5625 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of OncoTargets and Therapy is 2.67, which is computed in 2024 as per its definition. OncoTargets and Therapy IF is decreased by a factor of 1.21 and approximate percentage change is -31.19% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of OncoTargets and Therapy is 2.67. If the same downward trend persists, Impact IF may fall in 2024 as well.
Year | Impact IF |
---|---|
2023/2024 | Coming Soon |
2023 | 2.67 |
2022 | 3.88 |
2021 | 4.19 |
2020 | 3.80 |
2019 | 3.31 |
2018 | 3.16 |
2017 | 2.80 |
2016 | 2.86 |
2015 | 3.50 |
2014 | 3.26 |
OncoTargets and Therapy has an h-index of 86. It means 86 articles of this journal have more than 86 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of OncoTargets and Therapy is 11786930. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of OncoTargets and Therapy is 6118. According to SCImago Journal Rank (SJR), this journal is ranked 0.81. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
Year | SJR |
---|---|
2023/2024 | Coming Soon |
2023 | 0.81 |
2022 | 0.836 |
2021 | 0.811 |
2020 | 1.054 |
2019 | 0.954 |
2018 | 0.986 |
2017 | 0.967 |
2016 | 0.990 |
2015 | 1.140 |
2014 | 1.089 |
Year | Ranking |
---|---|
2023/2024 | Coming Soon |
2023 | 6118 |
2022 | 5608 |
2021 | 5618 |
2020 | 4052 |
2019 | 4641 |
2018 | 4456 |
2017 | 4570 |
2016 | 4489 |
2015 | 3687 |
2014 | 3817 |
OncoTargets and Therapy is published by Dove Medical Press Ltd.. It's publishing house is located in New Zealand. Coverage history of this journal is as following: 2009-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of OncoTargets and Therapy is OncoTargets Ther.. This abbreviation ('OncoTargets Ther.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Oncology (Q2); Pharmacology (medical) (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
OncoTargets and Therapy latest impact IF is 2.67. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 4.19 (2021) and 2.67 (2023), respectively, in the last 10 years. Moreover, its average IS is 3.34 in the previous 10 years.
The OncoTargets and Therapy has an SJR (SCImago Journal Rank) of 0.81, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 1.140 in 2015 and the lowest being 0.81 in 2023. Furthermore, the average SJR of the OncoTargets and Therapy over the previous 10-year period stands at 3.34.
The latest h-index of the OncoTargets and Therapy is 86.
The OncoTargets and Therapy is published by the Dove Medical Press Ltd., with its country of publication being the New Zealand.
The OncoTargets and Therapy is currently ranked 6118 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 3687 in 2015 and its lowest position of 6118 in 2023.
The standard ISO4 abbreviation for the OncoTargets and Therapy is OncoTargets Ther..
OncoTargets and Therapy is classified as a journal that the Dove Medical Press Ltd. publishes.
The OncoTargets and Therapy encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The OncoTargets and Therapy is assigned the following International Standard Serial Numbers (ISSN): 11786930.
The best quartile for the OncoTargets and Therapy is Q2 (2023).
The OncoTargets and Therapy coverage history can be summarized as follows: 2009-2023.
Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
---|---|---|---|---|---|
Journal of Field Archaeology | journal | 5619 | Maney Publishing | 45 | 1.64 |
Clinical Medicine and Research | journal | 14722 | Marshfield Clinic | 62 | 1.02 |
CESifo Economic Studies | journal | 9721 | Oxford University Press | 34 | 0.89 |
Milan Journal of Mathematics | journal | 3538 | Birkhauser Verlag Basel | 29 | 1.14 |
Journal of Business Finance and Accounting | journal | 2938 | Wiley-Blackwell Publishing Ltd | 91 | 3.64 |
Mathematical Modelling and Analysis | journal | 11193 | Vilnius Gediminas Technical University | 29 | 1.75 |
International Journal of Parallel, Emergent and Distributed Systems | journal | 16153 | Taylor and Francis Ltd. | 25 | 1.10 |
Journal, Indian Academy of Clinical Medicine | journal | 26979 | Indian Academy of Clinical Medicine | 16 | 0.10 |
Socialism and Democracy | journal | 25103 | Taylor and Francis Ltd. | 18 | 0.12 |
Tekstilec | trade journal | 18966 | University of Ljubljana Press | 15 | 0.91 |
Year | Impact Score (IS) |
---|---|
2024/2025 | Coming Soon |
2023 | 2.67 |
2022 | 3.88 |
2021 | 4.19 |
2020 | 3.80 |
2019 | 3.31 |
2018 | 3.16 |
2017 | 2.80 |
2016 | 2.86 |
2015 | 3.50 |
2014 | 3.26 |